Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present MediJane Holdings Inc. (OTC: MJMD).

Full DD Report for MJMD

You must become a subscriber to view this report.


Recent News from (OTC: MJMD)

Blue Dragon Ventures evolves out of MediJane Holdings Inc.
BOULDER, CO--(Marketwired - Nov 1, 2017) - MediJane Holdings, Inc. ("MediJane") a publicly-traded company ( OTC PINK : MJMD ), previously operating as a wholesaler and product distribution company within the legalized cannabis industries, is pleased to announce that it will become Blue Drag...
Source: Marketwired
Date: November, 01 2017 20:29

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-11-0124.0022.0024.0022.00590
2018-10-3124.0028.0028.0024.00666
2018-10-3021.0023.0023.0021.001,010
2018-10-2927.0021.0031.4821.001,292
2018-10-2621.0021.0021.0021.00216

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-0123059038.9831Short
2018-10-3146266669.3694Short
2018-10-304171,01041.2871Short
2018-10-297301,29256.5015Short
2018-10-267021632.4074Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MJMD.


About MediJane Holdings Inc. (OTC: MJMD)

Logo for MediJane Holdings Inc. (OTC: MJMD)

MediJane Holdings Inc MJMD is in the business of distributing transdermal patches, capsules, sublingual sprays and other medical delivery systems for the medical marijuana industry. With sales offices opening in California and Colorado, and then expanding into a national footprint, MediJane products are designed to give Doctors the ability to give patients accurate and effective doses of cannabinoids to manage and treat specific illnesses. As more and more is discovered about the uses of cannabis in modern medicine, a massive growth is being seen in this relatively new industry. Recently studies have been published siting treatment and/or management for fibromyalgia, migraine, PTSD, chronic pain and inflammation, autism, ADD/ADHD, crones disease, arthritis, seizures, epilepsy, skin cancer and various cancers. MediJane is positioned between the medical practitioners and the dispensary operators, our team of pharmaceutical and medical sales representatives provide the product and knowledge bridge between these two industry advocates of medical marijuana. Giving medical practitioners smokeless alternatives that not only are made from organically produced targeted strains of cannabis, but are able to allow the patient the ability to use the product safely and accurately. Many MediJane products are made without activating the psychotropic effects normally suffered or enjoyed by medical marijuana patients. The choice of products allows the patient to manage their condition, all without the traditional high , or where needed or desired, the activated product can provide the patient with a relaxation or sedative effect.

 

 

 

Current Management

  • Russell Stone / CEO, COO, Interim CFO
  • Jody Walker / General Counsel

Current Share Structure

  • Market Cap: $529,651 - 03/09/2018
  • Authorized: 1,000,000,000 - 02/28/2018
  • Issue and Outstanding: 34,171 - 02/28/2018

 


Recent Filings from (OTC: MJMD)

Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 26 2018

 

 


Daily Technical Chart for (OTC: MJMD)

Daily Technical Chart for (OTC: MJMD)


Stay tuned for daily updates and more on (OTC: MJMD)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MJMD)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MJMD is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MJMD and does not buy, sell, or trade any shares of MJMD. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/